+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Intranasal Drug & Vaccine Delivery Market - Global Forecast 2026-2032- Product Image
Intranasal Drug & Vaccine Delivery Market - Global Forecast 2026-2032- Product Image
New

Intranasal Drug & Vaccine Delivery Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 193 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5533387
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The intranasal drug and vaccine delivery market is undergoing notable change as advances in scientific research, device innovation, and new care models redefine global therapeutic strategies. Senior decision-makers will encounter a rapidly evolving industry where cross-functional integration and agile adaptation are key drivers of success.

Market Snapshot: Global Intranasal Drug & Vaccine Delivery

The intranasal drug and vaccine delivery market is on a steady upward trajectory. It expanded from USD 52.43 billion in 2025 to USD 55.44 billion in 2026 and is projected to reach USD 79.61 billion by 2032, reflecting a robust CAGR of 6.14%. This momentum is supported by growing demand for non-invasive therapeutics, accelerated adoption in pharmaceutical development, and initiatives by healthcare systems to broaden access to effective medicines. Enabling rapid drug absorption and supporting improved patient adherence, this market is increasingly favored for managing chronic conditions and implementing large-scale vaccine programs.

Scope & Segmentation

  • Drug Classes: Includes analgesics such as opioids and non-opioids, antihistamines for allergy management, steroids for inflammation control, and vaccines (inactivated, live attenuated, and mRNA-based) that address a broad range of therapeutic needs.
  • Formulation Platforms: Gel, liquid, and powder formulations are deployed, each optimized for stability, delivery efficiency, and user experience. These formats allow for tailored physician and patient selection based on treatment context.
  • Device Selection: Atomizers, nasal droppers, and nasal sprays offer reliability for precise administration. Each option provides unique usability features to suit targeted patient populations and care environments.
  • Dosage Formats: Multi-dose and unit-dose systems influence storage and logistics, supporting distribution models from centralized clinics to patient self-administration, while enhancing adherence strategies.
  • Clinical Applications: Indications range from allergy relief and hormone replacement to management of neurological disorders, pain, psychiatric conditions, and other areas requiring non-invasive therapeutic drug delivery.
  • End-User Environments: Homecare settings promote independence and adherence, while hospitals, clinics, and research centers impose requirements on device durability, labeling standards, and user training.
  • Geographic Regions: Americas, Europe, Middle East & Africa, and Asia-Pacific serve as primary regions, each presenting unique regulatory frameworks and commercialization pathways that shape access and innovation strategies.

Key Takeaways for Senior Decision-Makers

  • Integration of advances in formulation science, device engineering, and immunology is catalyzing an expanded range of clinical uses for intranasal delivery, moving beyond traditional indications.
  • Growth in home-administration and decentralized care models raises the demand for intuitive, patient-friendly devices and necessitates new training and distribution channels for broad user segments.
  • Increasing regulatory harmonization is facilitating product development, particularly for combination therapies, by simplifying clinical trial protocols and enabling faster multi-region launches.
  • Market segmentation highlights investment opportunities where technical maturity matches high unmet need, especially in next-generation vaccine formats and chronic disease management.
  • Vendor base diversification and adaptable supply chain solutions are essential to mitigate risk amid evolving procurement landscapes shaped by regional policy shifts and logistics changes.
  • Effective engagement with prescribers and patients, including comprehensive education and support initiatives, is necessary to ensure sustained uptake and maximize therapeutic outcomes.

Tariff Impact on Sourcing and Manufacturing

Recent shifts in tariffs and international trade policies are prompting device manufacturers and pharmaceutical firms to reassess sourcing and production decisions. To manage increased landed costs for materials and components, many are expanding their supplier base, moving manufacturing closer to key markets, and investing in multiple regional partners. These measures help reduce dependency on single regions and buffer against supply disruptions. Modular designs and flexible product configurations support operational resilience as policy environments continue to evolve.

Methodology & Data Sources

This analysis leverages a comprehensive review of current scientific studies, regulatory documents, and technical white papers, alongside primary interviews and global supply chain mapping. Input from subject matter experts and scenario planning ensures findings bridge laboratory feasibility with real-world deployment needs and operational constraints.

Why This Report Matters

  • Empowers executive leadership with clear insights for investment, portfolio management, and supply chain strategy by aligning market trends and technology adoption with practical market access pathways.
  • Clarifies the interactions between regulatory shifts, supply chain resilience, and diverse market segments to support timely and effective go-to-market decisions.
  • Equips business leaders and cross-functional teams to manage risk, refine regional commercialization strategies, and target high-priority opportunities for innovation and partnership.

Conclusion

Market success in intranasal drug and vaccine delivery relies on coordinated investments in science, technology, and supply chain agility. Senior leaders who integrate these elements will be best positioned to capture value and advance therapeutic reach globally.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Intranasal Drug & Vaccine Delivery Market, by Drug Type
8.1. Analgesics
8.1.1. Non-opioids
8.1.2. Opioids
8.2. Antihistamines
8.3. Steroids
8.4. Vaccines
8.4.1. Inactivated Vaccines
8.4.2. Live Attenuated Vaccines
8.4.3. mRNA-based Vaccine
9. Intranasal Drug & Vaccine Delivery Market, by Formulation Type
9.1. Gel Formulations
9.2. Liquid Formulations
9.3. Powder Formulations
10. Intranasal Drug & Vaccine Delivery Market, by Device Type
10.1. Atomizer
10.2. Nasal Dropper
10.3. Nasal Spray
11. Intranasal Drug & Vaccine Delivery Market, by Dosage
11.1. Multi-dose
11.2. Unit-dose
12. Intranasal Drug & Vaccine Delivery Market, by Application
12.1. Allergy Treatment
12.2. Hormone Replacement
12.3. Neurological Conditions
12.4. Pain Management
12.5. Psychiatric Disorders
12.6. Therapeutic Drug Delivery
13. Intranasal Drug & Vaccine Delivery Market, by End-User
13.1. Homecare
13.2. Hospitals & Clinics
13.3. Research & Academic Institution
14. Intranasal Drug & Vaccine Delivery Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Intranasal Drug & Vaccine Delivery Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Intranasal Drug & Vaccine Delivery Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Intranasal Drug & Vaccine Delivery Market
18. China Intranasal Drug & Vaccine Delivery Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. Altimmune, Inc.
19.6. AptarGroup, Inc.
19.7. AstraZeneca PLC
19.8. Bausch Health Companies Inc.
19.9. Bayer AG
19.10. Becton, Dickinson, and Company
19.11. Bharat Biotech Ltd.
19.12. Boehringer Ingelheim International GmbH.
19.13. Catalent, Inc
19.14. DCA Design International Limited
19.15. Emergent BioSolutions Inc.
19.16. GlaxoSmithKline PLC
19.17. Hovione Limited
19.18. Impel Pharmaceuticals LLC.
19.19. Indivior PLC
19.20. Intersect ENT by Medtronic plc
19.21. Intertek Group PLC
19.22. Johnson & Johnson Services, Inc.
19.23. Kindeva Drug Delivery L.P.
19.24. Merck & Co., Inc.
19.25. Neurelis, Inc.
19.26. Novartis AG
19.27. OptiNose, Inc.
19.28. Pfizer Inc.
19.29. Recipharm AB.
19.30. Sanofi S.A.
19.31. Teleflex Incorporated
19.32. Teva Pharmaceutical Industries Ltd.
List of Figures
FIGURE 1. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DRUG TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ANALGESICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ANALGESICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ANALGESICS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY NON-OPIOIDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY NON-OPIOIDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY NON-OPIOIDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY OPIOIDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY OPIOIDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY OPIOIDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ANTIHISTAMINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ANTIHISTAMINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ANTIHISTAMINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY STEROIDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY STEROIDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY STEROIDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY INACTIVATED VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY INACTIVATED VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY MRNA-BASED VACCINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY MRNA-BASED VACCINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY MRNA-BASED VACCINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY GEL FORMULATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY GEL FORMULATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY GEL FORMULATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY POWDER FORMULATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY POWDER FORMULATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY POWDER FORMULATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ATOMIZER, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ATOMIZER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ATOMIZER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY NASAL DROPPER, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY NASAL DROPPER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY NASAL DROPPER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY NASAL SPRAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY NASAL SPRAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY NASAL SPRAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY MULTI-DOSE, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY MULTI-DOSE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY MULTI-DOSE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY UNIT-DOSE, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY UNIT-DOSE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY UNIT-DOSE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ALLERGY TREATMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ALLERGY TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ALLERGY TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY HORMONE REPLACEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY HORMONE REPLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY HORMONE REPLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY NEUROLOGICAL CONDITIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY NEUROLOGICAL CONDITIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY NEUROLOGICAL CONDITIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PSYCHIATRIC DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PSYCHIATRIC DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PSYCHIATRIC DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY THERAPEUTIC DRUG DELIVERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY THERAPEUTIC DRUG DELIVERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY THERAPEUTIC DRUG DELIVERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY HOMECARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY HOMECARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY HOMECARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. AMERICAS INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 90. AMERICAS INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 91. AMERICAS INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ANALGESICS, 2018-2032 (USD MILLION)
TABLE 92. AMERICAS INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 93. AMERICAS INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
TABLE 94. AMERICAS INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 95. AMERICAS INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 96. AMERICAS INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 97. AMERICAS INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 98. NORTH AMERICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. NORTH AMERICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 100. NORTH AMERICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ANALGESICS, 2018-2032 (USD MILLION)
TABLE 101. NORTH AMERICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 102. NORTH AMERICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
TABLE 103. NORTH AMERICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 104. NORTH AMERICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 105. NORTH AMERICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 106. NORTH AMERICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 107. LATIN AMERICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. LATIN AMERICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 109. LATIN AMERICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ANALGESICS, 2018-2032 (USD MILLION)
TABLE 110. LATIN AMERICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 111. LATIN AMERICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
TABLE 112. LATIN AMERICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 113. LATIN AMERICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 114. LATIN AMERICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 115. LATIN AMERICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ANALGESICS, 2018-2032 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 125. EUROPE INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. EUROPE INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 127. EUROPE INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ANALGESICS, 2018-2032 (USD MILLION)
TABLE 128. EUROPE INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 129. EUROPE INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
TABLE 130. EUROPE INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 131. EUROPE INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 132. EUROPE INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 133. EUROPE INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 134. MIDDLE EAST INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 135. MIDDLE EAST INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 136. MIDDLE EAST INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ANALGESICS, 2018-2032 (USD MILLION)
TABLE 137. MIDDLE EAST INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 138. MIDDLE EAST INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
TABLE 139. MIDDLE EAST INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 140. MIDDLE EAST INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 141. MIDDLE EAST INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 142. MIDDLE EAST INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 143. AFRICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. AFRICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 145. AFRICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ANALGESICS, 2018-2032 (USD MILLION)
TABLE 146. AFRICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 147. AFRICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
TABLE 148. AFRICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 149. AFRICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 150. AFRICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 151. AFRICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 152. ASIA-PACIFIC INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 153. ASIA-PACIFIC INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 154. ASIA-PACIFIC INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ANALGESICS, 2018-2032 (USD MILLION)
TABLE 155. ASIA-PACIFIC INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 156. ASIA-PACIFIC INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
TABLE 157. ASIA-PACIFIC INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 158. ASIA-PACIFIC INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 159. ASIA-PACIFIC INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 160. ASIA-PACIFIC INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 162. ASEAN INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 163. ASEAN INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 164. ASEAN INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ANALGESICS, 2018-2032 (USD MILLION)
TABLE 165. ASEAN INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 166. ASEAN INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
TABLE 167. ASEAN INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 168. ASEAN INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 169. ASEAN INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 170. ASEAN INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 171. GCC INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 172. GCC INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 173. GCC INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ANALGESICS, 2018-2032 (USD MILLION)
TABLE 174. GCC INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 175. GCC INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
TABLE 176. GCC INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 177. GCC INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 178. GCC INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 179. GCC INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 180. EUROPEAN UNION INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 181. EUROPEAN UNION INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 182. EUROPEAN UNION INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ANALGESICS, 2018-2032 (USD MILLION)
TABLE 183. EUROPEAN UNION INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 184. EUROPEAN UNION INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
TABLE 185. EUROPEAN UNION INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 186. EUROPEAN UNION INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 187. EUROPEAN UNION INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 188. EUROPEAN UNION INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 189. BRICS INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 190. BRICS INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 191. BRICS INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ANALGESICS, 2018-2032 (USD MILLION)
TABLE 192. BRICS INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 193. BRICS INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
TABLE 194. BRICS INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 195. BRICS INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 196. BRICS INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 197. BRICS INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 198. G7 INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 199. G7 INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 200. G7 INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ANALGESICS, 2018-2032 (USD MILLION)
TABLE 201. G7 INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 202. G7 INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
TABLE 203. G7 INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 204. G7 INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 205. G7 INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 206. G7 INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 207. NATO INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 208. NATO INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 209. NATO INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ANALGESICS, 2018-2032 (USD MILLION)
TABLE 210. NATO INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 211. NATO INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
TABLE 212. NATO INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 213. NATO INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 214. NATO INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 215. NATO INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 216. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 217. UNITED STATES INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 218. UNITED STATES INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 219. UNITED STATES INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ANALGESICS, 2018-2032 (USD MILLION)
TABLE 220. UNITED STATES INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 221. UNITED STATES INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
TABLE 222. UNITED STATES INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 223. UNITED STATES INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 224. UNITED STATES INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 225. UNITED STATES INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 226. CHINA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 227. CHINA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 228. CHINA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ANALGESICS, 2018-2032 (USD MILLION)
TABLE 229. CHINA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 230. CHINA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
TABLE 231. CHINA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 232. CHINA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 233. CHINA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 234. CHINA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Intranasal Drug & Vaccine Delivery market report include:
  • Altimmune, Inc.
  • AptarGroup, Inc.
  • AstraZeneca PLC
  • Bausch Health Companies Inc.
  • Bayer AG
  • Becton, Dickinson, and Company
  • Bharat Biotech Ltd.
  • Boehringer Ingelheim International GmbH.
  • Catalent, Inc
  • DCA Design International Limited
  • Emergent BioSolutions Inc.
  • GlaxoSmithKline PLC
  • Hovione Limited
  • Impel Pharmaceuticals LLC.
  • Indivior PLC
  • Intersect ENT by Medtronic plc
  • Intertek Group PLC
  • Johnson & Johnson Services, Inc.
  • Kindeva Drug Delivery L.P.
  • Merck & Co., Inc.
  • Neurelis, Inc.
  • Novartis AG
  • OptiNose, Inc.
  • Pfizer Inc.
  • Recipharm AB.
  • Sanofi S.A.
  • Teleflex Incorporated
  • Teva Pharmaceutical Industries Ltd.

Table Information

Report AttributeDetails
No. of Pages193
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 55.44 Billion
Forecasted Market Value ( USD ) by 2032 $ 79.61 Billion
Compound Annual Growth Rate6.1%
Regions CoveredGlobal
No. of Companies Mentioned29

Related Topics

Related Reports

Vaccine Delivery Devices - Global Strategic Business Report - Product Image

Vaccine Delivery Devices - Global Strategic Business Report

  • Report
  • 282 Pages
  • Global
From
Vaccine Delivery Devices Market - Global Forecast 2026-2032 - Product Image

Vaccine Delivery Devices Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
Vaccine Delivery Devices Market Report 2025 - Product Image

Vaccine Delivery Devices Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Vaccine Delivery Device Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Vaccine Delivery Device Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Vaccine Delivery Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Vaccine Delivery Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 182 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.